Last reviewed · How we verify
Propofol Injection Emulsion
At a glance
| Generic name | Propofol Injection Emulsion |
|---|---|
| Sponsor | Beijing Chao Yang Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Hypotension
- Nausea
- Procedural Pain
- Procedural Hypotension
- Hypertension
- Asthenia
- Hypoxia
- Vomitting
- Dizziness
- Tachycardia
- Bradycardia
- Constipation
Key clinical trials
- Propofol vs Remifentanil for Sedation in Gastroscopy (NA)
- A Study of Remimazolam Tosilate for Sedation in the ICU (PHASE3)
- Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General Anesthesia (PHASE3)
- Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery (PHASE3)
- Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective Surgery (PHASE3)
- Bioequivalence Study of Propofol Medium and Long Chain Fat Emulsion Injection in Healthy Chinese Subjects (PHASE1)
- Respiratory Effect of the LISA Method with Sedation by Propofol Versus Absence of Sedation. (PHASE3)
- Postoperative Quality of Recovery After General Anesthesia With Remimazolam (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Propofol Injection Emulsion CI brief — competitive landscape report
- Propofol Injection Emulsion updates RSS · CI watch RSS
- Beijing Chao Yang Hospital portfolio CI